Rossari Biotech Limited (NSE:ROSSARI)
533.50
+2.35 (0.44%)
Jan 23, 2026, 3:29 PM IST
Rossari Biotech Revenue
Rossari Biotech had revenue of 5.82B INR in the quarter ending December 31, 2025, with 13.45% growth. This brings the company's revenue in the last twelve months to 22.91B, up 16.09% year-over-year. In the fiscal year ending March 31, 2025, Rossari Biotech had annual revenue of 20.80B with 13.64% growth.
Revenue (ttm)
22.91B
Revenue Growth
+16.09%
P/S Ratio
1.29
Revenue / Employee
42.82M
Employees
535
Market Cap
29.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 20.80B | 2.50B | 13.64% |
| Mar 31, 2024 | 18.31B | 1.75B | 10.55% |
| Mar 31, 2023 | 16.56B | 1.73B | 11.66% |
| Mar 31, 2022 | 14.83B | 7.74B | 109.06% |
| Mar 31, 2021 | 7.09B | 1.09B | 18.21% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Savita Oil Technologies | 40.16B |
| Laxmi Organic Industries | 28.89B |
| S H Kelkar and Company | 22.41B |
| Veedol Corporation | 20.38B |
| Jubilant Agri and Consumer Products | 17.51B |
| NOCIL | 13.15B |
| Neogen Chemicals | 8.00B |
| Advanced Enzyme Technologies | 7.07B |
Rossari Biotech News
- 4 days ago - Rossari Biotech Ltd (BOM:543213) Q3 2026 Earnings Call Highlights: Navigating Growth Amidst ... - GuruFocus
- 4 days ago - Q3 2026 Rossari Biotech Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Rossari Biotech Ltd (BOM:543213) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus
- 2 months ago - Q2 2026 Rossari Biotech Ltd Earnings Call Transcript - GuruFocus
- 1 year ago - Rossari Biotech’s subsidiary wins GST appeal; previous tax order set aside - Business Upturn
- 1 year ago - Rossari Biotech Ltd (BOM:543213) Q3 2025 Earnings Call Highlights: Strong Export Growth and ... - GuruFocus
- 1 year ago - Q3 2025 Rossari Biotech Ltd Earnings Call Transcript - GuruFocus
- 1 year ago - Rossari Biotech stock drops 4.28% following Q2 results - Business Upturn